BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bogdanov G, Bogdanov I, Kazandjieva J, Tsankov N. Cutaneous adverse effects of the available COVID-19 vaccines. Clin Dermatol 2021;39:523-31. [PMID: 34518015 DOI: 10.1016/j.clindermatol.2021.04.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 44.0] [Reference Citation Analysis]
Number Citing Articles
1 Aryanian Z, Balighi K, Azizpour A, Kamyab Hesari K, Hatami P. Coexistence of Pemphigus Vulgaris and Lichen Planus following COVID-19 Vaccination. Case Reports in Dermatological Medicine 2022;2022:1-5. [DOI: 10.1155/2022/2324212] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Rueda-Fernández M, Melguizo-Rodríguez L, Costela-Ruiz VJ, González-Acedo A, Ramos-Torrecillas J, Illescas-Montes R. The current status of COVID-19 vaccines. A scoping review. Drug Discov Today 2022:S1359-6446(22)00306-3. [PMID: 35995361 DOI: 10.1016/j.drudis.2022.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yavuz E, Turgut K, Gulacti U, Aydın Î, Ozcan O, Sonmez C, Arslan EB. Side Effects Related to BNT162b2 and CoronaVac Vaccine Requiring Emergency Department Visit. Avicenna J Med. [DOI: 10.1055/s-0042-1750391] [Reference Citation Analysis]
4 SeyedAlinaghi S, Karimi A, Pashaei Z, Afzalian A, Mirzapour P, Ghorbanzadeh K, Ghasemzadeh A, Dashti M, Nazarian N, Vahedi F, Tantuoyir MM, Shamsabadi A, Dadras O, Mehraeen E. Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review. Arch Acad Emerg Med 2022;10:e41. [PMID: 35765616 DOI: 10.22037/aaem.v10i1.1597] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Magdalena Dumitru I. Side Effects of the COVID-19 Vaccines. COVID-19 Vaccines - Current State and Perspectives [Working Title] 2022. [DOI: 10.5772/intechopen.105668] [Reference Citation Analysis]
6 Potestio L, Genco L, Villani A, Marasca C, Fabbrocini G, Fornaro L, Ruggiero A, Martora F. Reply to 'Cutaneous adverse effects of the available COVID-19 vaccines in India: A questionnaire-based study'. by Bawane J et al. J Eur Acad Dermatol Venereol 2022. [PMID: 35723893 DOI: 10.1111/jdv.18341] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
7 Jo E. Adverse Reactions of COVID-19 Vaccines. J Clin Otolaryngol Head Neck Surg 2022;33:92-104. [DOI: 10.35420/jcohns.2022.33.2.92] [Reference Citation Analysis]
8 Kalantari Y, Aryanian Z, Mirahmadi SM, Alilou S, Hatami P, Goodarzi A. A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles. J Cosmet Dermatol 2022. [PMID: 35534886 DOI: 10.1111/jocd.15071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ahmed SK, Mohamed MG, Essa RA, Ahmed Rashad Dabou EA, Abdulqadir SO, Omar RM. Global reports of takotsubo (stress) cardiomyopathy following COVID-19 vaccination: a systematic review and meta-analysis.. [DOI: 10.1101/2022.04.16.22273937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Aryanian Z, Balighi K, Hatami P, Tootoonchi NM, Goodarzi A, Mohseni Afshar Z. Morphea in two patients after being infected to and being vaccinated against SARS‐CoV‐2 infection. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Iyidobi EC, Iyidobi TO, Ozioko US, Onu JU, Muomah RC, Iorfa SK, Aneke AV. Vaccine hesitancy: Pattern of side effects of the first dose of AstraZeneca COVID-19 vaccine among healthcare workers in Enugu. Ann Clin Biomed Res 2022;3. [DOI: 10.4081/acbr.2022.174] [Reference Citation Analysis]
12 Pour Mohammad A, Mashayekhi F, Seirafianpour F, Gholizadeh Mesgarha M, Goodarzi A. COVID‐19 and COVID‐19 vaccine‐related dermatological reactions: An interesting case series with a narrative review of the potential critical and non‐critical mucocutaneous adverse effects related to virus, therapy, and the vaccination. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5775] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Belete TM. The Immune Response, Safety, and Efficacy of Emergency Use Authorization-Granted COVID-19 Vaccines: A Review. TOMICROJ 2022;16:e187428582201240. [DOI: 10.2174/18742858-v16-e2201240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rabail R, Ahmed W, Ilyas M, Rajoka MSR, Hassoun A, Khalid AR, Khan MR, Aadil RM. The Side Effects and Adverse Clinical Cases Reported after COVID-19 Immunization. Vaccines (Basel) 2022;10:488. [PMID: 35455237 DOI: 10.3390/vaccines10040488] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Shanshal M. Eruptive Angiomatosis Triggered by COVID-19 Vaccination. Cureus. [DOI: 10.7759/cureus.22907] [Reference Citation Analysis]
16 Metin Z, Celepli P. A case of morphea following the COVID ‐19 mRNA vaccine: on the basis of viral spike proteins. Int J Dermatology. [DOI: 10.1111/ijd.16062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
17 Tiwari P, Kumar A, Shrivastava S. Management of adverse events post-COVID-19 vaccination with Covaxin and Covishield: A literature review. One Health Bull 2022;2:6. [DOI: 10.4103/2773-0344.347378] [Reference Citation Analysis]
18 Sil A, Jakhar D, Das A, Jagadeesan S, Aradhya SS. Spectrum of Mucocutaneous Reactions to COVID-19 Vaccination: A Report from a Web-Based Study from India. Indian J Dermatol 2022;67:115-20. [PMID: 36092222 DOI: 10.4103/ijd.ijd_893_21] [Reference Citation Analysis]
19 Brooks SG, De Jong AM, Abbaslou M, Sussman G. Chronic Spontaneous Urticaria Triggered by the AstraZeneca/Oxford COVID-19 Vaccine with Achieved Remission: A Case Report. Allergy Rhinol (Providence) 2022;13:21526567211068458. [PMID: 35036040 DOI: 10.1177/21526567211068458] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
20 Kothari RS, Subramani D, Asnani DR, Raman A, Deora MS, Gupta A. Erythema multiforme after Covishield/ChAdOx1 vaccination. Dermatol Ther 2021;:e15289. [PMID: 34962029 DOI: 10.1111/dth.15289] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Pourani MR, Shahidi Dadras M, Salari M, Diab R, Namazi N, Abdollahimajd F. Cutaneous adverse events related to COVID-19 vaccines: A cross-sectional questionnaire-based study of 867 patients. Dermatol Ther 2021;:e15223. [PMID: 34820975 DOI: 10.1111/dth.15223] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
22 Gronbeck C, Grant-Kels JM. Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them! Clin Dermatol 2021;39:674-87. [PMID: 34809772 DOI: 10.1016/j.clindermatol.2021.05.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
23 Rademacher JG, Tampe B, Korsten P. First Report of Two Cases of Löfgren's Syndrome after SARS-CoV-2 Vaccination-Coincidence or Causality? Vaccines (Basel) 2021;9:1313. [PMID: 34835244 DOI: 10.3390/vaccines9111313] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
24 Cameli N, Silvestri M, Mariano M, Bennardo L, Nisticò SP, Cristaudo A. Erythema nodosum following the first dose of ChAdOx1-S nCoV-19 vaccine. J Eur Acad Dermatol Venereol 2021. [PMID: 34662466 DOI: 10.1111/jdv.17762] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 10.0] [Reference Citation Analysis]
25 Gambichler T, Boms S, Susok L, Dickel H, Finis C, Abu Rached N, Barras M, Stücker M, Kasakovski D. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience. J Eur Acad Dermatol Venereol 2021. [PMID: 34661927 DOI: 10.1111/jdv.17744] [Cited by in Crossref: 53] [Cited by in F6Publishing: 61] [Article Influence: 53.0] [Reference Citation Analysis]
26 Otani J, Ohta R, Sano C. Association between Immunoglobulin G Levels and Adverse Effects Following Vaccination with the BNT162b2 Vaccine among Japanese Healthcare Workers. Vaccines (Basel) 2021;9:1149. [PMID: 34696257 DOI: 10.3390/vaccines9101149] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
27 Brooks SG, Alhusayen R, Piguet V, Croitoru D. Pfizer/BioNTech-associated perniosis in two young adults with re-challenge evidence. J Eur Acad Dermatol Venereol 2021. [PMID: 34606671 DOI: 10.1111/jdv.17719] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Majid I, Mearaj S. Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female. Dermatol Ther 2021;34:e15146. [PMID: 34590397 DOI: 10.1111/dth.15146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
29 Niebel D, Wenzel J, Wilsmann-Theis D, Ziob J, Wilhelmi J, Braegelmann C. Single-Center Clinico-Pathological Case Study of 19 Patients with Cutaneous Adverse Reactions Following COVID-19 Vaccines. Dermatopathology (Basel) 2021;8:463-76. [PMID: 34698094 DOI: 10.3390/dermatopathology8040049] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
30 Essam R, Ehab R, Al-Razzaz R, Khater MW, Moustafa EA. Alopecia areata after ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca): a potential triggering factor? J Cosmet Dermatol 2021;20:3727-9. [PMID: 34559937 DOI: 10.1111/jocd.14459] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
31 Solomon Y, Eshete T, Mekasha B, Assefa W. COVID-19 Vaccine: Side Effects After the First Dose of the Oxford AstraZeneca Vaccine Among Health Professionals in Low-Income Country: Ethiopia. J Multidiscip Healthc 2021;14:2577-85. [PMID: 34556992 DOI: 10.2147/JMDH.S331140] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 15.0] [Reference Citation Analysis]
32 Niebel D, Novak N, Wilhelmi J, Ziob J, Wilsmann-Theis D, Bieber T, Wenzel J, Braegelmann C. Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective. Vaccines (Basel) 2021;9:944. [PMID: 34579181 DOI: 10.3390/vaccines9090944] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 32.0] [Reference Citation Analysis]
33 Heck E, Rankin BD, Schneider M, Prajapati VH. Flagellate purpura associated with COVID-19 vaccination. J Eur Acad Dermatol Venereol 2021. [PMID: 34416052 DOI: 10.1111/jdv.17609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Lim PN, Wylie G. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination. Clin Exp Dermatol 2022;47:175-6. [PMID: 34399001 DOI: 10.1111/ced.14898] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
35 Makhlouf M, Akl J, Ammoury A. Varicella Zoster Reactivation Following mRNA Vaccination: Two Case Reports and a Review of Cutaneous Adverse Events of COVID-19 Vaccines. EMJ. [DOI: 10.33590/emj/21-00254] [Reference Citation Analysis]
36 Cernat MC, Ali S, Bumbăcea RS. Cutaneous adverse effects of COVID-19 vaccines: what do we know so far? Alergologia 2021;2:62. [DOI: 10.26416/aler.5.2.2021.4898] [Reference Citation Analysis]